Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 49 min ago
Peer-reviewedCC BY 4.0Frontiers in Immunology

The cGAS-STING pathway in traumatic brain injury: mechanisms of neuroinflammation and therapeutic strategies

Abstract

Traumatic brain injury (TBI) remains a leading cause of mortality and long-term disability worldwide, and no pharmacological therapy interrupts the deleterious secondary injury cascade. Damage-associated molecular patterns (DAMPs), particularly mislocalized nuclear and mitochondrial DNA, drive self-sustained neuroinflammation by activating the cytosolic DNA-sensing cGAS–STING pathway to trigger type-I interferon and NF-κB-dependent transcription. This review summarizes cGAS-STING molecular features, cell-specific activation, temporal kinetics and therapeutic strategies in TBI. Genetic studies from focal and diffuse injury models demonstrate that cGAS-STING ablation lessens lesion volume, mitigates neuroinflammation and preserves cognitive function, with microglia acting as the predominant cellular mediator. Clinical observations show that cell-free mitochondrial DNA, a major cGAS ligand, is markedly elevated in severe TBI patients’ cerebrospinal fluid and serum, correlating with injury severity and prognosis, while aging amplifies pathway activation. Positioned at the intersection of DAMP sensing, glial reactivity, cell-death signaling and chronic neurodegeneration, cGAS-STING represents a highly promising therapeutic target for post-traumatic neuroinflammation.

Related

  1. The cGAS–STING pathway in tumor immunity: dual roles, regulatory mechanisms, and precision therapeutic strategies
    H B Jiang, Zhanzhan Li, X X Li +5
    Frontiers in PharmacologyPeer-reviewedCC BYFull text9 citedImmunologyOpenAlex
  2. Pharmacological cGAS-STING pathway inhibition on neuroinflammation in animal models of traumatic brain injury: A systematic review and meta-analysis protocol
    Myriam Lamamri, Stéphanie Sigaut, Hélène Cwerman-Thibault +5
    PLOS OnePeer-reviewedCC BY 4.0ImmunologyStatisticsPLOS
  3. The gasdermin family in depression-associated neuroinflammation: established evidence, emerging mechanisms, and therapeutic perspectives
    Yang Luo, Ziming Liu, Huiqin Li +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
  4. Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
    Michelle Diane Rudman, Jason D. Ulrich, David M. Holtzman
    CellPeer-reviewedCC BY-NC-ND10 citedNeurosciencePhysiologyOpenAlex
  5. Neural regulation of tumor immune evasion and immunotherapy resistance: mechanisms and therapeutic strategies
    Ningxin Li, Hongzhe Wei, Shengbo Jin +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiers
BibTeX
@article{chen2026cgassting,
  title = {{The cGAS-STING pathway in traumatic brain injury: mechanisms of neuroinflammation and therapeutic strategies}},
  author = {Bing Chen and Duochang Tu and Rong Zhang and Chuang Nie and Quanxing Shi and Cheng-teng Jiang and Feiyi Sun and Xiangrong Pu and Li Zhang and Qiang Zhou and Jian-wen Gu},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = oct,
  doi = {10.3389/fimmu.2026.1987328},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1987328},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The cGAS-STING pathway in traumatic brain injury: mechanisms of neuroinflammation and therapeutic strategies
AU  - Bing Chen
AU  - Duochang Tu
AU  - Rong Zhang
AU  - Chuang Nie
AU  - Quanxing Shi
AU  - Cheng-teng Jiang
AU  - Feiyi Sun
AU  - Xiangrong Pu
AU  - Li Zhang
AU  - Qiang Zhou
AU  - Jian-wen Gu
PY  - 2026
DA  - 2026/10/30
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1987328
UR  - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1987328
AB  - Traumatic brain injury (TBI) remains a leading cause of mortality and long-term disability worldwide, and no pharmacological therapy interrupts the deleterious secondary injury cascade. Damage-associated molecular patterns (DAMPs), particularly mislocalized nuclear and mitochondrial DNA, drive self-sustained neuroinflammation by activating the cytosolic DNA-sensing cGAS–STING pathway to trigger type-I interferon and NF-κB-dependent transcription. This review summarizes cGAS-STING molecular features, cell-specific activation, temporal kinetics and therapeutic strategies in TBI. Genetic studies from focal and diffuse injury models demonstrate that cGAS-STING ablation lessens lesion volume, mitigates neuroinflammation and preserves cognitive function, with microglia acting as the predominant cellular mediator. Clinical observations show that cell-free mitochondrial DNA, a major cGAS ligand, is markedly elevated in severe TBI patients’ cerebrospinal fluid and serum, correlating with injury severity and prognosis, while aging amplifies pathway activation. Positioned at the intersection of DAMP sensing, glial reactivity, cell-death signaling and chronic neurodegeneration, cGAS-STING represents a highly promising therapeutic target for post-traumatic neuroinflammation.
SN  - 1664-3224
ER  -